hsa-miR-186-3p

ncRNA information

ncRNA

hsa-miR-186-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Prognosis

Upstream regulatory factor

Not available

Downstream target

Not available

Differential expression in
recurrence vs. nonrecurrence

Not available

Cancer information

Cancer name

Gastrointestinal Stromal Tumors

Alias

Soft Tissue Sarcoma

Cancer site

Stomach

Recurrence type

Metastatic Recurrence

Clinical information

Overall survival rate of patients with
high ncRNA expression

Up

ncRNA differential expression in
cancer patients vs. health people

Not available

Number of patients

100

Male patients

44

Female patients

56

Age range and number

56(<=65)+44(>65)


Recurrence patients

Not available

Recurrence patients male:female

Not available

Recurrence patients age range

Not available

Recurrence mean age

Not available

Sites of recurrence

Not available


Patients without recurrence

Not available

Patients without recurrence male:female

Patients without recurrence age range

Not available

Patients without recurrence mean age

Not available

Research information

PMID

Description

These results suggest that the downregulation of miR-186 is involved in the metastatic recurrence of GISTs, and that miR-186 levels could potentially be a predictive biomarker for clinical outcome.

Tissue resource

Experiment

qRT-PCR,Microarray analysis


Institute

Country

Continent